Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Clonal Selection in Therapy Related Myelodysplastic Syndromes Under Azacitidine Treatment

Anne Calleja, Chimene Moreilhon, PhD, Jean Michel Karsenti, MD, Lauris Gastaud, MD, Lionel Mannone, MD, Berengere Dadone, MD, Guillaume Robert, PhD, Patrick Auberger, PhD, Sophie Raynaud, MD PhD, Thomas Cluzeau, MDPhD

Blood (2017) 130 (Supplement 1): 5297.

https://doi.org/10.1182/blood.V130.Suppl_1.5297.5297

Published: 2017

Journal Articles

Implication of the Anti-Apoptotic Protein Bcl-B (BCL2L10) in the Pathogenesis of Multiple Myeloma

Valentine Richez, Jr., MD, Frederic Luciano, PhD, Amine Hamouda, PhD, Alexandre Puissant, Guillaume Robert, PhD, Arnaud Jacquel, PhD, Thomas Cluzeau, MDPhD, Kenneth C Anderson, MD, Jean-Gabriel Fuzibet, MD, Patrick Auberger, PhD

Blood (2015) 126 (23): 2958.

https://doi.org/10.1182/blood.V126.23.2958.2958

Published: 2015

Journal Articles

Decreased Expression of Anti-DNMT1 Tumor-Suppressor microRNAs in Azacitidine (AZA)-Resistant Cells Independently Predicts Survival in Patients Treated with AZA for Higher Risk Myelodysplastic Syndrome (HRMDS) and Oligoblastic Acute Myeloid Leukemia (AML)

Francoise Solly, MD, Catherine Koering, PhD, Aminetou mint Mohamed, PhD, Delphine Maucort-Boulch, MD, Guillaume Robert, PhD, Patrick Auberger, PhD, Pascale Flandrin-Gresta, MDPhD, Lionel Adès, MD PhD, Pierre Fenaux, MD PhD, Olivier Kosmider, MD PhD, Emmanuelle Tavernier-Tardy, MDPhD, Jérôme Cornillon, MD, Denis Guyotat, MDPhD, Lydia Campos, MD PhD, Franck Mortreux, PhD, Eric Wattel, MDPhD

Blood (2015) 126 (23): 2840.

https://doi.org/10.1182/blood.V126.23.2840.2840

Published: 2015

Journal Articles

CD9, a key actor in the dissemination of lymphoblastic leukemia, modulating CXCR4-mediated migration via RAC1 signaling

Marie-Pierre Arnaud, Audrey Vallée, Guillaume Robert, Jacinthe Bonneau, Christine Leroy, Nadine Varin-Blank, Anne-Gaëlle Rio, Marie-Bérengère Troadec, Marie-Dominique Galibert, Virginie Gandemer

Blood (2015) 126 (15): 1802–1812.

https://doi.org/10.1182/blood-2015-02-628560

Published: 2015

Includes: Supplemental data

Journal Articles

BCL2L10 Quantification Is a Predictive Factor of Response to Azacitidine in Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)

Valerie Vidal, Clemence Ginet, Jean Michel Karsenti, MD, Frederic Luciano, PhD, Lauris Gastaud, MD, Georges Garnier, MD, Thorsten Braun, MD, Pierre Hirsch, MD, Emmanuel Raffoux, MD, Anne Marie Nloga, Herve Dombret, MD, Pierre-Simon Rohrlich, Lionel Ades, MD PhD, Christine Chomienne, MD PhD, Pierre Fenaux, MD PhD, Patrick Auberger, PhD, Guillaume Robert, PhD, Thomas Cluzeau, MD PhD

Blood (2014) 124 (21): 3261.

https://doi.org/10.1182/blood.V124.21.3261.3261

Published: 2014

Journal Articles

The P2Y6-AMPK Pathway Triggers Autophagy during CSF-1-Induced Human Monocyte Differentiation and Is a Potential Target in CMML

Sandrine Obba, PhDstudent, Zoheir Hizir, PhDstudent, Dorothée Selimoglu-Buet, PhD, Laurent Boyer, PhD, Anja Pfeifer, PhD, Mohamed-Amine Hamouda, PhDstudent, Diogo Goncalves, Michael Cerezo, PhDstudent, Sandrine Marchetti, PhD, Stephane Rocchi, PhD, Nathalie Droin, PhD, Guillaume Robert, PhD, Frederic Luciano, PhD, Bernard Robaye, PhD, Benoit Viollet, PhD, Laurence Legros, MD PhD, Eric Solary, MD PhD, Patrick Auberger, PhD, Arnaud Jacquel, PhD

Blood (2014) 124 (21): 4347.

https://doi.org/10.1182/blood.V124.21.4347.4347

Published: 2014

Journal Articles

Disruption of CD9 Expression Affects Adhesion, Migration, and Actin Polymerization through RAC1 Signalling Pathway in ETV6/RUNX1 Pre-B Lymphocytes

Marie-Pierre Arnaud, Audrey Vallée, PhD, Guillaume Robert, Jacinthe Bonneau, MD, Elisabetta Dondi, PhD, Christine Le Roy, PhD, Nadine Varin-Blank, PhD, Marie-Dominique Galibert, PhD PharmD, Marie-Bérengère Troadec, PhD, Virginie Gandemer

Blood (2014) 124 (21): 1080.

https://doi.org/10.1182/blood.V124.21.1080.1080

Published: 2014

Journal Articles

Evaluation Of Acadesine, a Drug Stimulating Cell Autophagy, In Azacitidine(AZA)-Resistant Myelodysplastic Syndromes (MDS)

Thomas Cluzeau, MD, PhD, Guillaume Robert, PhD, Jean Michel Karsenti, MD, Frederic Luciano, PhD, Nicolas Mounier, MD, PhD, Jill Patrice Cassuto, MD, PhD, Lionel Ades, Sophie Raynaud, MD, PhD, Pierre Fenaux, MD, PhD, Patrick Auberger, PhD

Blood (2013) 122 (21): 1568.

https://doi.org/10.1182/blood.V122.21.1568.1568

Published: 2013

Journal Articles

Disruption Of CD9 Expression Affects Adhesion, Migration and Engraftment Of Pre-B Lymphocytes

Marie-Pierre Arnaud, Audrey Vallée, PhD, Guillaume Robert, Anne-Gaelle Rio, Elisabetta Dondi, PhD, Jacinthe Bonneau, MD, Christine LE ROY, PhD, Nadine Varin-Blank, PhD, Marie-Dominique Galibert, PhD, PharmD, Marie-Bérengère Troadec, PhD, Virginie Gandemer, MD, PhD

Blood (2013) 122 (21): 1222.

https://doi.org/10.1182/blood.V122.21.1222.1222

Published: 2013

Journal Articles

BCL2L10 (Bcl-B) Is Associated with Resistance to Azacitidine (AZA) in MDS and AML, and Is a Possible Therapeutic Target in AZA Resistant Patients

Thomas Cluzeau, MD, PhD, Guillaume Robert, Jean-Michel Karsenti, MD, Frederic Luciano, Alexandre Puissant, Faezeh Legrand, MD, PhD, Lionel Mannone, MD, Aline Renneville, MD, Claude Preudhomme, Pierre Fenaux, MD, PhD, Jill-Patrice Cassuto, MD, Sophie Raynaud, Nicolas Mounier, MD, PhD, Patrick Auberger, MD, PhD

Blood (2012) 120 (21): 701.

https://doi.org/10.1182/blood.V120.21.701.701

Published: 2012

Journal Articles

Autophagy is required for CSF-1–induced macrophagic differentiation and acquisition of phagocytic functions

Arnaud Jacquel, Sandrine Obba, Laurent Boyer, Maeva Dufies, Guillaume Robert, Pierre Gounon, Emmanuel Lemichez, Frederic Luciano, Eric Solary, Patrick Auberger

Blood (2012) 119 (19): 4527–4531.

https://doi.org/10.1182/blood-2011-11-392167

Published: 2012

Includes: Supplemental data

Journal Articles

Induction of Autophagic Cell Death Circumvents Azacitidine-Resistance In Myelodysplastic Syndrome-Derived Cell Lines

Thomas Cluzeau, Guillaume Robert, Jean-Michel Karsenti, Frederic Luciano, Alexandre Puissant, S. Dominique Raynaud, MD, Lionel Mannone, Jill-Patrice Cassuto, Nicolas Mounier, Patrick Auberger

Blood (2010) 116 (21): 1817.

https://doi.org/10.1182/blood.V116.21.1817.1817

Published: 2010

NARROW

Clonal Selection in Therapy Related Myelodysplastic Syndromes Under Azacitidine Treatment

Implication of the Anti-Apoptotic Protein Bcl-B (BCL2L10) in the Pathogenesis of Multiple Myeloma

Decreased Expression of Anti-DNMT1 Tumor-Suppressor microRNAs in Azacitidine (AZA)-Resistant Cells Independently Predicts Survival in Patients Treated with AZA for Higher Risk Myelodysplastic Syndrome (HRMDS) and Oligoblastic Acute Myeloid Leukemia (AML)

CD9, a key actor in the dissemination of lymphoblastic leukemia, modulating CXCR4-mediated migration via RAC1 signaling

BCL2L10 Quantification Is a Predictive Factor of Response to Azacitidine in Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)

The P2Y6-AMPK Pathway Triggers Autophagy during CSF-1-Induced Human Monocyte Differentiation and Is a Potential Target in CMML

Disruption of CD9 Expression Affects Adhesion, Migration, and Actin Polymerization through RAC1 Signalling Pathway in ETV6/RUNX1 Pre-B Lymphocytes

Evaluation Of Acadesine, a Drug Stimulating Cell Autophagy, In Azacitidine(AZA)-Resistant Myelodysplastic Syndromes (MDS)

Disruption Of CD9 Expression Affects Adhesion, Migration and Engraftment Of Pre-B Lymphocytes

BCL2L10 (Bcl-B) Is Associated with Resistance to Azacitidine (AZA) in MDS and AML, and Is a Possible Therapeutic Target in AZA Resistant Patients

Autophagy is required for CSF-1–induced macrophagic differentiation and acquisition of phagocytic functions

Induction of Autophagic Cell Death Circumvents Azacitidine-Resistance In Myelodysplastic Syndrome-Derived Cell Lines

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only